Avidian Wealth Enterprises’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-31,000
| Closed | -$504K | – | 452 |
|
|
2022
Q1 | $504K | Hold |
31,000
| – | – | 0.03% | 294 |
|
|
2021
Q4 | $429K | Hold |
31,000
| – | – | 0.03% | 321 |
|
|
2021
Q3 | $445K | Hold |
31,000
| – | – | 0.03% | 230 |
|
|
2021
Q2 | $490K | Buy |
31,000
+1,000
| +3% | +$15.8K | 0.04% | 226 |
|
|
2021
Q1 | $305K | Buy |
+30,000
| New | +$305K | 0.03% | 282 |
|